Tag: Quiremspheres
QuiremScout shows superior predictive value to technetium 99m macroaggregated albumin during...
A recent study comparing holmium-166 (QuiremSpheres, from Terumo) to technetium-99m-macroaggregated albumin (99mTc-MAA) as a work up for selective internal radiation therapy (SIRT) has found...
QuiremScout, the first and only product indicated for SIRT work-up, receives...
QuiremScout (Quirem Medical) has received CE mark, making it available for clinical centres throughout Europe. QuiremScout is designed to advance the SIRT (selective internal...
Terumo launches QuiremSpheres microspheres in Europe
Terumo has announced that it has launched QuiremSpheres microspheres in Europe on 18 September.
QuiremSpheres, the next generation of selective internal radiation therapy (SIRT) microspheres...
Terumo announces first commercial clinical case using Quiremspheres
Terumo Europe NV has announced the first commercial clinical case using Quiremspheres—the next generation radioembolization microspheres for advanced unresectable liver cancer.
Quiremspheres are the only...
